218 related articles for article (PubMed ID: 36165730)
1. Human Papillomavirus-Directed Therapeutics for Human Papillomavirus-Associated Oropharyngeal Cancer.
Campbell JS; Pai SI
Cancer J; 2022 Sep-Oct 01; 28(5):407-415. PubMed ID: 36165730
[TBL] [Abstract][Full Text] [Related]
2. Human Papillomavirus Associated Cancers of the Head and Neck: An Australian Perspective.
Aldalwg MAH; Brestovac B
Head Neck Pathol; 2017 Sep; 11(3):377-384. PubMed ID: 28176136
[TBL] [Abstract][Full Text] [Related]
3. Current Status of Human Papillomavirus-Targeted Therapies Development in Head and Neck Cancer.
Park JC; Bertaux B; Park J; Park S
JCO Precis Oncol; 2023 Jun; 7():e2300098. PubMed ID: 37315264
[TBL] [Abstract][Full Text] [Related]
4. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy in HPV-Related Oropharyngeal Cancers.
Roof L; Yilmaz E
Curr Treat Options Oncol; 2023 Mar; 24(3):170-183. PubMed ID: 36719604
[TBL] [Abstract][Full Text] [Related]
6. Human Papillomavirus and Risk of Head and Neck Squamous Cell Carcinoma in Iran.
Karimi A; Mohebbi E; Mckay-Chopin S; Rashidian H; Hadji M; Peyghambari V; Marzban M; Naghibzadeh-Tahami A; Gholipour M; Kamangar F; Tommasino M; Gheit T; Zendehdel K
Microbiol Spectr; 2022 Aug; 10(4):e0011722. PubMed ID: 35708339
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Vaccines for HPV-Associated Oropharyngeal and Cervical Cancer: The Next De-Intensification Strategy?
Morand GB; Cardona I; Cruz SBSC; Mlynarek AM; Hier MP; Alaoui-Jamali MA; da Silva SD
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955529
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of human papillomavirus in head and neck cancers at tertiary care centers in the United States over time.
Scott-Wittenborn N; D'Souza G; Tewari S; Rooper L; Troy T; Drake V; Bigelow EO; Windon MJ; Ryan WR; Ha PK; Kiess AP; Miles B; Westra WH; Mydlarz WK; Eisele DW; Fakhry C
Cancer; 2022 May; 128(9):1767-1774. PubMed ID: 35132635
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus and head and neck squamous cell carcinoma in a UK population: Is there an association?
Al-Dabbagh R; Al-Hazmi N; Alhazzazi TY; Barrett AW; Speight PM
Indian J Cancer; 2022; 59(1):65-72. PubMed ID: 33753602
[TBL] [Abstract][Full Text] [Related]
10. Assessing plasma circulating tumor human papillomavirus (HPV) DNA in determining treatment response in HPV-associated oropharyngeal cancer.
Zarrabi KK; Galloway TJ; Flieder DB; Kumar SS; Judd J; Bauman JR
Head Neck; 2022 Aug; 44(8):E25-E30. PubMed ID: 35546490
[TBL] [Abstract][Full Text] [Related]
11. miRNAs in human papilloma virus associated oral and oropharyngeal squamous cell carcinomas.
Salazar C; Calvopiña D; Punyadeera C
Expert Rev Mol Diagn; 2014 Nov; 14(8):1033-40. PubMed ID: 25222489
[TBL] [Abstract][Full Text] [Related]
12. The role of human papillomavirus infection in head and neck cancers.
Syrjänen S
Ann Oncol; 2010 Oct; 21 Suppl 7():vii243-5. PubMed ID: 20943622
[TBL] [Abstract][Full Text] [Related]
13. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
[TBL] [Abstract][Full Text] [Related]
14. Awareness of Human Papillomavirus (HPV) and HPV Vaccination amongst the General Population in Germany: Lack of Awareness and Need for Action.
Sharma SJ; Schartinger VH; Wuerdemann N; Langer C; Möllenhoff K; Collin L; Sutton L; Riedl D; Kreuter A; Lechner M; Wieland U; Klussmann JP
Oncol Res Treat; 2022; 45(10):561-567. PubMed ID: 35850111
[TBL] [Abstract][Full Text] [Related]
15. Human Papillomavirus Impact on Temporal Treatment Trends in Oropharyngeal Carcinoma: 2010-2016.
Amin N; Thompson J; Goloubeva O; Witek M; Taylor RJ; Wolf JS; Moyer K; Mehra R; Hatten KM
ORL J Otorhinolaryngol Relat Spec; 2022; 84(6):438-446. PubMed ID: 36067748
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus-related oropharyngeal carcinoma.
Saito Y; Homma A; Kiyota N; Tahara M; Hanai N; Asakage T; Matsuura K; Ota I; Yokota T; Sano D; Kodaira T; Motegi A; Yasuda K; Takahashi S; Tanaka K; Onoe T; Okano S; Imamura Y; Ariizumi Y; Hayashi R
Jpn J Clin Oncol; 2022 Jul; 52(7):700-706. PubMed ID: 35383359
[TBL] [Abstract][Full Text] [Related]
17. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
Jain KS; Sikora AG; Baxi SS; Morris LG
Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
[TBL] [Abstract][Full Text] [Related]
18. Human Papillomavirus and Oropharyngeal Cancer.
Tanaka TI; Alawi F
Dent Clin North Am; 2018 Jan; 62(1):111-120. PubMed ID: 29126488
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of human papillomavirus types, viral load and physical status of HPV16 in head and neck squamous cell carcinoma from the South Swedish Health Care Region.
Faust H; Eldenhed Alwan E; Roslin A; Wennerberg J; Forslund O
J Gen Virol; 2016 Nov; 97(11):2949-2956. PubMed ID: 27667722
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus in oropharyngeal cancer: The changing face of a disease.
Mallen-St Clair J; Alani M; Wang MB; Srivatsan ES
Biochim Biophys Acta; 2016 Dec; 1866(2):141-150. PubMed ID: 27487173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
